Phenominer Database Results (19 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
WF.WKY-(D5Uwm76-D5Uwm61)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 40 4.2 null 0.4 2.53 in vivo visual assessment 0.0 0 70297 653
WF.WKY-(D5Uwm76-D5Got18)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 27 3.5 null 0.4 2.08 in vivo visual assessment 0.0 0 70300 653
WF.WKY-(D5Uwm76-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 4.8 null 0.4 3.05 in vivo visual assessment 0.0 0 70304 653
WF.WKY-(D5Uwm78-D5Uwm93)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 27 5.0 null 0.5 2.6 in vivo visual assessment 0.0 0 70306 653
WF.WKY-(D5Uwm77-D5Uwm91)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 12 3.8 null 0.8 2.77 in vivo visual assessment 0.0 0 70313 653
WF.WKY-(D5Uwm67-D5Uwm78)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 32 8.6 null 0.8 4.53 in vivo visual assessment 0.0 0 70299 653
WF.WKY-(D5Uwm88-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 6.9 null 0.6 4.57 in vivo visual assessment 0.0 0 70308 653
WF.WKY-(D5Uwm95-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 36 7.4 null 0.6 3.6 in vivo visual assessment 0.0 0 70302 653
WF.WKY-(D5Uwm78-D5Uwm84)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 29 8.8 null 0.7 3.77 in vivo visual assessment 0.0 0 70305 653
WF/NHsd mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 46 7.9 null 0.5 3.39 in vivo visual assessment 0.0 0 70314 653
WF.WKY-(D5Uwm67-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 35 3.2 null 0.4 2.37 in vivo visual assessment 0.0 0 70296 653
WF.WKY-(D5Uwm78-D5Uwm84)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 41 8.1 null 0.6 3.84 in vivo visual assessment 0.0 0 70307 653
WF.WKY-(D5Uwm85-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 51 3.9 null 0.3 2.14 in vivo visual assessment 0.0 0 70310 653
WF.WKY-(D5Uwm76-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 26 3.8 null 0.4 2.04 in vivo visual assessment 0.0 0 70298 653
WF.WKY-(D5Uwm78-D5Uwm98)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 32 2.8 null 0.3 1.7 in vivo visual assessment 0.0 0 70301 653
WF.WKY-(D5Uwm67-D5Uwm81)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 26 8.3 null 0.7 3.57 in vivo visual assessment 0.0 0 70303 653
WF.WKY-(D5Uwm82-D5Uwm91)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 58 3.4 null 0.3 2.28 in vivo visual assessment 0.0 0 70312 653
WF.WKY-(D5Uwm82-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 18 2.6 null 0.6 2.55 in vivo visual assessment 0.0 0 70311 653
WF.WKY-(D5Uwm87-D5Uwm92)/Uwm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days) Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. mammary gland integrity trait female 155 days-160 days 56 6.3 null 0.4 2.99 in vivo visual assessment 0.0 0 70309 653